Sudden Cardiac Death

Compared with placebo, dapagliflozin reduced risk for ventricular arrhythmias, cardiac arrest and sudden death, according to new data from the DAPA-HF trial.

Elevated concentrations of serum oxalate were associated with an increased risk for cardiovascular mortality, most notably from sudden cardiac death, according to a post-hoc analysis of the German Diabetes Dialysis Study.

Sudden cardiac death in people with HIV vs. those without.

AAP’s new policy statement that recommended all children — not just those who engage in sports — be screened for CVD was the top story in cardiology last week.

Higher Mediterranean diet score trended toward association with lower 10-year risk for sudden cardiac death, whereas higher Southern diet score trended toward association with higher 10-year sudden cardiac death risk, researchers reported.

In a new policy statement, the AAP said all children — particularly those entering middle school — should be screened for conditions that can lead to cardiac arrest or death, regardless of their athletic status.

Compared with those without HIV, HIV-positive individuals had higher rates of sudden cardiac death and myocardial fibrosis, and one-third of sudden cardiac deaths in people with HIV were due to occult drug overdose, researchers reported.

The diagnosis of depression is strongly associated with increased risk for sudden cardiac death and HF events in patients with hypertrophic cardiomyopathy, researchers reported.

Among patients with non-ST-segment elevation ACS, a higher relative proportion of plasma long-chain omega-3 polyunsaturated fatty acid was associated with lower chances of sudden cardiac death, researchers reported.

The FDA recently approved a therapy that combines rosuvastatin, a statin for LDL reduction, and ezetimibe, a cholesterol absorption inhibitor, for adults with primary nonfamilial hyperlipidemia or homozygous familial hypercholesterolemia.